Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of CryoPort Inc (NASDAQ: CYRX) was $5.49 for the day, up 2.71% from the previous closing price of $5.34. In other words, the price has increased by $2.71 from its previous closing price. On the day, 0.5 million shares were traded. CYRX stock price reached its highest trading level at $5.735 during the session, while it also had its lowest trading level at $4.8883.
Ratios:
Our analysis of CYRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.57.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.
Jefferies Downgraded its Buy to Hold on August 07, 2024, whereas the target price for the stock was revised from $20 to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when Sawicki Mark W sold 1,349 shares for $6.94 per share. The transaction valued at 9,364 led to the insider holds 84,087 shares of the business.
STEFANOVICH ROBERT sold 1,070 shares of CYRX for $7,428 on Mar 24 ’25. The Chief Financial Officer now owns 190,349 shares after completing the transaction at $6.94 per share. On Mar 24 ’25, another insider, SHELTON JERRELL, who serves as the President, CEO of the company, sold 2,980 shares for $6.94 each. As a result, the insider received 20,686 and left with 762,419 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 274008096 and an Enterprise Value of 290000032. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.20 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 1.27 whereas that against EBITDA is -8.2.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.85, which has changed by -0.708444 over the last 52 weeks, in comparison to a change of -0.028342128 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $19.00, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is -14.55%, while the 200-Day Moving Average is calculated to be -26.77%.
Shares Statistics:
CYRX traded an average of 427.32K shares per day over the past three months and 534380 shares per day over the past ten days. A total of 49.91M shares are outstanding, with a floating share count of 48.07M. Insiders hold about 3.68% of the company’s shares, while institutions hold 95.83% stake in the company. Shares short for CYRX as of 1741910400 were 2227901 with a Short Ratio of 5.21, compared to 1739491200 on 2082876. Therefore, it implies a Short% of Shares Outstanding of 2227901 and a Short% of Float of 5.3600002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
